Abstract
There is tremendous potential for patients to benefit from recent advances in optical technologies and molecular imaging approaches. While these clinical applications are just beginning, the data from preclinical studies indicate significant improvements in early detection of cancerous growth and metastasis by various optical-based techniques.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abe, H., J. Wang, K. Furukawa, K. Oki, M. Uda, S. Tsuneda, and Y. Ito, A reduction-triggered fluorescence probe for sensing nucleic acids. Bioconjug Chem, 2008. 19(6): 1219–26.
Adusumilli, P.S., B.M. Stiles, M.K. Chan, D.P. Eisenberg, Z. Yu, S.F. Stanziale, R. Huq, R.J. Wong, V.W. Rusch, and Y. Fong, Real-time diagnostic imaging of tumors and metastases by use of a replication-competent herpes vector to facilitate minimally invasive oncological surgery. Faseb J, 2006. 20(6): 726–8.
Bading, J.R. and A.F. Shields, Imaging of cell proliferation: status and prospects. J Nucl Med, 2008. 49 Suppl 2: 64S–80S.
Ballou, B., G.W. Fisher, J.S. Deng, T.R. Hakala, M. Srivastava, and D.L. Farkas, Cyanine fluorochrome-labeled antibodies in vivo: assessment of tumor imaging using Cy3, Cy5, Cy5.5, and Cy7. Cancer Detect Prev, 1998. 22(3): 251–7.
Ballou, B., G.W. Fisher, T.R. Hakala, and D.L. Farkas, Tumor detection and visualization using cyanine fluorochrome-labeled antibodies. Biotechnol Prog, 1997. 13(5): 649–58.
Becker, A., C. Hessenius, S. Bhargava, C. Grotzinger, K. Licha, J. Schneider-Mergener, B. Wiedenmann, and W. Semmler, Cyanine dye labeled vasoactive intestinal peptide and somatostatin analog for optical detection of gastroenteropancreatic tumors. Ann N Y Acad Sci, 2000. 921: 275–8.
Becker, A., C. Hessenius, K. Licha, B. Ebert, U. Sukowski, W. Semmler, B. Wiedenmann, and C. Grotzinger, Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol, 2001. 19(4): 327–31.
Bennett, J., D. Duan, J.F. Engelhardt, and A.M. Maguire, Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction. Invest Ophthalmol Vis Sci, 1997. 38(13): 2857–63.
Cai, W. and X. Chen, Multimodality molecular imaging of tumor angiogenesis. J Nucl Med, 2008. 49 Suppl 2: 113S–28S.
Chaudhuri, T.R., Z. Cao, V.N. Krasnykh, A.V. Stargel, N. Belousova, E.E. Partridge, and K.R. Zinn, Blood-based screening and light based imaging for the early detection and monitoring of ovarian cancer xenografts. Technol Cancer Res Treat, 2003. 2(2): 171–80.
Chaudhuri, T.R., Z. Cao, B.E. Rogers, E.E. Partridge, and K.R. Zinn, Non-invasive light-based imaging of GFP-positive ovarian xenografts. Abstract Book p. 70, Annual Investigators' Workshop, 2001a.
Chaudhuri, T.R., Z. Cao, E.E. Partridge, and K.R. Zinn, A comparative analysis of optical and gamma camera imaging for non-invasive detection of ovarian cancer. Eur J Nucl Med Mol I, 2002. 29(1):s229.
Chaudhuri, T.R., J.M. Mountz, B.E. Rogers, E.E. Partridge, and K.R. Zinn, Light-based imaging of green fluorescent protein-positive ovarian cancer xenografts during therapy. Gynecol Oncol, 2001b. 82(3): 581–9.
Chenevert, T.L., L.D. Stegman, J.M. Taylor, P.L. Robertson, H.S. Greenberg, A. Rehemtulla, and B.D. Ross, Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst, 2000. 92(24): 2029–36.
Chirmule, N., S.E. Raper, L. Burkly, D. Thomas, J. Tazelaar, J.V. Hughes, and J.M. Wilson, Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40-CD40 ligand interactions. J Virol, 2000. 74(7): 3345–52.
Chishima, T., Y. Miyagi, L. Li, Y. Tan, E. Baranov, M. Yang, H. Shimada, A.R. Moossa, and R.M. Hoffman, Use of histoculture and green fluorescent protein to visualize tumor cell host interaction. In Vitro Cell Dev Biol Anim, 1997a. 33(10): 745–7.
Chishima, T., Y. Miyagi, X. Wang, Y. Tan, H. Shimada, A. Moossa, and R.M. Hoffman, Visualization of the metastatic process by green fluorescent protein expression. Anticancer Res, 1997b. 17(4A): 2377–84.
Chishima, T., Y. Miyagi, X. Wang, H. Yamaoka, H. Shimada, A.R. Moossa, and R.M. Hoffman, Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res, 1997c. 57(10): 2042–7.
Chishima, T., M. Yang, Y. Miyagi, L. Li, Y. Tan, E. Baranov, H. Shimada, A.R. Moossa, S. Penman, and R.M. Hoffman, Governing step of metastasis visualized in vitro. Proc Natl Acad Sci USA, 1997d. 94(21): 11573–6.
Dardalhon, V., N. Noraz, K. Pollok, C. Rebouissou, M. Boyer, A.Q. Bakker, H. Spits, and N. Taylor, Green fluorescent protein as a selectable marker of fibronectin- facilitated retroviral gene transfer in primary human T lymphocytes. Hum Gene Ther, 1999. 10(1): 5–14.
Eisenberg, D.P., P.S. Adusumilli, K.J. Hendershott, S. Chung, Z. Yu, M.K. Chan, M. Hezel, R.J. Wong, and Y. Fong, Real-time intraoperative detection of breast cancer axillary lymph node metastases using a green fluorescent protein-expressing herpes virus. Ann Surg, 2006. 243(6): 824–30; discussion 830–2.
Fingleton, B., R. Menon, K.J. Carter, P.D. Overstreet, D.L. Hachey, L.M. Matrisian, and J.O. McIntyre, Proteinase activity in human and murine saliva as a biomarker for proteinase inhibitor efficacy. Clin Cancer Res, 2004. 10(23): 7865–74.
Galons, J.P., M.I. Altbach, G.D. Paine-Murrieta, C.W. Taylor, and R.J. Gillies, Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia, 1999. 1(2): 113–7.
Gee, M.S., R. Upadhyay, H. Bergquist, H. Alencar, F. Reynolds, M. Maricevich, R. Weissleder, L. Josephson, and U. Mahmood, Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy. Radiology, 2008. 248(3): 925–35.
Gleysteen, J.P., J.R. Newman, D. Chhieng, A. Frost, K.R. Zinn, and E.L. Rosenthal, Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model. Head Neck, 2008. 30(6): 782–9.
Grab, D., F. Flock, I. Stohr, K. Nussle, A. Rieber, S. Fenchel, H.J. Brambs, S.N. Reske, and R. Kreienberg, Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography. Gynecol Oncol, 2000. 77(3): 454–9.
Gurfinkel, M., A.B. Thompson, W. Ralston, T.L. Troy, A.L. Moore, T.A. Moore, J.D. Gust, D. Tatman, J.S. Reynolds, B. Muggenburg, K. Nikula, R. Pandey, R.H. Mayer, D.J. Hawrysz, and E.M. Sevick-Muraca, Pharmacokinetics of ICG and HPPH-car for the detection of normal and tumor tissue using fluorescence, near-infrared reflectance imaging: a case study. Photochem Photobiol, 2000. 72(1): 94–102.
Hoffman, R.M., The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer, 2005. 5(10): 796–806.
Hoffman, J.M., S.S. Gambhir, and G.J. Kelloff, Regulatory and reimbursement challenges for molecular imaging. Radiology, 2007. 245(3): 645–60.
Joshi, A., W. Bangerth, K. Hwang, J.C. Rasmussen, and E.M. Sevick-Muraca, Fully adaptive FEM based fluorescence optical tomography from time-dependent measurements with area illumination and detection. Med Phys, 2006. 33(5): 1299–310.
Kozloff, K.M., L. Quinti, C. Tung, R. Weissleder, and U. Mahmood, Non-invasive imaging of osteoclast activity via near-infrared cathepsin-K activatable optical probe. J Musculoskelet Neuronal Interact, 2006. 6(4): 353.
Kubik-Huch, R.A., W. Dorffler, G.K. von Schulthess, B. Marincek, O.R. Kochli, B. Seifert, U. Haller, and H.C. Steinert, Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma. Eur Radiol, 2000. 10(5): 761–7.
Kurjak, A., S. Kupesic, V. Sparac, and D. Kosuta, Three-dimensional ultrasonographic and power Doppler characterization of ovarian lesions. Ultrasound Obstet Gynecol, 2000. 16(4): 365–71.
Le, L.P., J. Li, V.V. Ternovoi, G.P. Siegal, and D.T. Curiel, Fluorescently tagged canine adenovirus via modification with protein IX-enhanced green fluorescent protein. J Gen Virol, 2005. 86(Pt 12): p. 3201–8.
Li, C., T.R. Greenwood, and K. Glunde, Glucosamine-bound near-infrared fluorescent probes with lysosomal specificity for breast tumor imaging. Neoplasia, 2008. 10(4): 389–98.
Li, C.Y., S. Shan, Q. Huang, R.D. Braun, J. Lanzen, K. Hu, P. Lin, and M.W. Dewhirst, Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models. J Natl Cancer Inst, 2000. 92(2): 143–7.
Licha, K., C. Hessenius, A. Becker, P. Henklein, M. Bauer, S. Wisniewski, B. Wiedenmann, and W. Semmler, Synthesis, characterization, and biological properties of cyanine- labeled somatostatin analogues as receptor-targeted fluorescent probes. Bioconjug Chem, 2001. 12(1): 44–50.
Lisy, M.R., A. Goermar, C. Thomas, J. Pauli, U. Resch-Genger, W.A. Kaiser, and I. Hilger, In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice. Radiology, 2008. 247(3): 779–87.
Liu, G., H.S. Rugo, G. Wilding, T.M. McShane, J.L. Evelhoch, C. Ng, E. Jackson, F. Kelcz, B.M. Yeh, F.T. Lee, Jr., C. Charnsangavej, J.W. Park, E.A. Ashton, H.M. Steinfeldt, Y.K. Pithavala, S.D. Reich, and R.S. Herbst, Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. J Clin Oncol, 2005. 23(24): 5464–73.
Mahmood, U., C.H. Tung, A. Bogdanov, Jr., and R. Weissleder, Near-infrared optical imaging of protease activity for tumor detection. Radiology, 1999. 213(3): 866–70.
Mahmood, U. and R. Weissleder, Near-infrared optical imaging of proteases in cancer. Mol Cancer Ther, 2003. 2(5): 489–96.
Mankoff, D.A., J.M. Link, H.M. Linden, L. Sundararajan, and K.A. Krohn, Tumor receptor imaging. J Nucl Med, 2008. 49 Suppl 2: 149S–63S.
Martin, B.R., B.N. Giepmans, S.R. Adams, and R.Y. Tsien, Mammalian cell-based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity. Nat Biotechnol, 2005. 23(10): 1308–14.
McIntyre, J.O., B. Fingleton, K.S. Wells, D.W. Piston, C.C. Lynch, S. Gautam, and L.M. Matrisian, Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity. Biochem J, 2004. 377(Pt 3): 617–28.
McIntyre, J.O. and L.M. Matrisian, Molecular imaging of proteolytic activity in cancer. J Cell Biochem, 2003. 90(6): 1087–97.
Ntziachristos, V., A.G. Yodh, M. Schnall, and B. Chance, Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci U S A, 2000. 97(6): 2767–72.
Nunn, A.D., The cost of developing imaging agents for routine clinical use. Invest Radiol, 2006. 41(3): 206–12.
Nunn, A.D., The cost of bringing a radiopharmaceutical to the patient's bedside. J Nucl Med, 2007. 48(2): 169.
Peng, L., R. Liu, M. Andrei, W. Xiao, and K.S. Lam, In vivo optical imaging of human lymphoma xenograft using a library-derived peptidomimetic against alpha4beta1 integrin. Mol Cancer Ther, 2008. 7(2): 432–7.
Pfeifer, A., T. Kessler, M. Yang, E. Baranov, N. Kootstra, D.A. Cheresh, R.M. Hoffman, and I.M. Verma, Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging. Mol Ther, 2001. 3(3): 319–22.
Pickles, M.D., P. Gibbs, M. Lowry, and L.W. Turnbull, Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging, 2006. 24(7): 843–7.
Plathow, C. and W.A. Weber, Tumor cell metabolism imaging. J Nucl Med, 2008. 49 Suppl 2: 43S–63S.
Ramjiawan, B., P. Maiti, A. Aftanas, H. Kaplan, D. Fast, H.H. Mantsch, and M. Jackson, Noninvasive localization of tumors by immunofluorescence imaging using a single chain Fv fragment of a human monoclonal antibody with broad cancer specificity. Cancer, 2000. 89(5): 1134–44.
Reynolds, J.S., T.L. Troy, R.H. Mayer, A.B. Thompson, D.J. Waters, K.K. Cornell, P.W. Snyder, and E.M. Sevick-Muraca, Imaging of spontaneous canine mammary tumors using fluorescent contrast agents. Photochem Photobiol, 1999. 70(1): 87–94.
Rocconi, R.P., Z.B. Zhu, M. Stoff-Khalili, A.A. Rivera, B. Lu, M. Wang, R.D. Alvarez, D.T. Curiel, and S.K. Makhija, Treatment of ovarian cancer with a novel dual targeted conditionally replicative adenovirus (CRAd). Gynecol Oncol, 2007. 105(1): 113–21.
Rosenthal, E.L., B.D. Kulbersh, T. King, T.R. Chaudhuri, and K.R. Zinn, Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts. Mol Cancer Ther, 2007. 6(4): 1230–8.
Scherer, R.L., J.O. McIntyre, and L.M. Matrisian, Imaging matrix metalloproteinases in cancer. Cancer Metastasis Rev, 2008. 27(4): 679–90.
Sevick-Muraca, E.M., R. Sharma, J.C. Rasmussen, M.V. Marshall, J.A. Wendt, H.Q. Pham, E. Bonefas, J.P. Houston, L. Sampath, K.E. Adams, D.K. Blanchard, R.E. Fisher, S.B. Chiang, R. Elledge, and M.E. Mawad, Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. Radiology, 2008. 246(3): 734–41.
Shaner, N.C., M.Z. Lin, M.R. McKeown, P.A. Steinbach, K.L. Hazelwood, M.W. Davidson, and R.Y. Tsien, Improving the photostability of bright monomeric orange and red fluorescent proteins. Nat Methods, 2008. 5(6): 545–51.
Shaner, N.C., P.A. Steinbach, and R.Y. Tsien, A guide to choosing fluorescent proteins. Nat Methods, 2005. 2(12): 905–9.
Shcherbo, D., E.M. Merzlyak, T.V. Chepurnykh, A.F. Fradkov, G.V. Ermakova, E.A. Solovieva, K.A. Lukyanov, E.A. Bogdanova, A.G. Zaraisky, S. Lukyanov, and D.M. Chudakov, Bright far-red fluorescent protein for whole-body imaging. Nat Methods, 2007. 4(9): 741–6.
Shibata, A., K. Furukawa, H. Abe, S. Tsuneda, and Y. Ito, Rhodamine-based fluorogenic probe for imaging biological thiol. Bioorg Med Chem Lett, 2008. 18(7): 2246–9.
Stoff-Khalili, M.A., A.A. Rivera, J.M. Mathis, N.S. Banerjee, A.S. Moon, A. Hess, R.P. Rocconi, T.M. Numnum, M. Everts, L.T. Chow, J.T. Douglas, G.P. Siegal, Z.B. Zhu, H.G. Bender, P. Dall, A. Stoff, L. Pereboeva, and D.T. Curiel, Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Res Treat, 2007. 105(2): 157–67.
Stoff-Khalili, M.A., A.A. Rivera, A. Nedeljkovic-Kurepa, A. DeBenedetti, X.L. Li, Y. Odaka, J. Podduturi, D.A. Sibley, G.P. Siegal, A. Stoff, S. Young, Z.B. Zhu, D.T. Curiel, and J.M. Mathis, Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control. Breast Cancer Res Treat, 2008. 108(1): 43–55.
Stummer, W., U. Pichlmeier, T. Meinel, O.D. Wiestler, F. Zanella, and H.J. Reulen, Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol, 2006. 7(5): 392–401.
Su, M.Y., H.M. Baik, H.J. Yu, J.H. Chen, R.S. Mehta, and O. Nalcioglu, Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI. Technol Cancer Res Treat, 2006. 5(4): 401–10.
Takayama, K., P.N. Reynolds, Y. Adachi, L. Kaliberova, J. Uchino, Y. Nakanishi, and D.T. Curiel, Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses for pan-carcinoma application. Cancer Gene Ther, 2007. 14(1): 105–16.
Tempany, C.M., K.H. Zou, S.G. Silverman, D.L. Brown, A.B. Kurtz, and B.J. McNeil, Staging of advanced ovarian cancer: comparison of imaging modalities– report from the Radiological Diagnostic Oncology Group. Radiology, 2000. 215(3): 761–7.
Wahl, R.L., Overview of the current status of PET in breast cancer imaging. Q J Nucl Med, 1998. 42(1): 1–7.
Weissleder, R., C.H. Tung, U. Mahmood, and A. Bogdanov, Jr., In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol, 1999. 17(4): 375–8.
Wester, H.J., Nuclear imaging probes: from bench to bedside. Clin Cancer Res, 2007. 13(12): 3470–81.
Wilmes, L.J., M.G. Pallavicini, L.M. Fleming, J. Gibbs, D. Wang, K.L. Li, S.C. Partridge, R.G. Henry, D.R. Shalinsky, D. Hu-Lowe, J.W. Park, T.M. McShane, Y. Lu, R.C. Brasch, and N.M. Hylton, AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Imaging, 2007. 25(3): 319–27.
Withrow, K.P., J.P. Gleysteen, A. Safavy, J. Skipper, R.A. Desmond, K. Zinn, and E.L. Rosenthal, Assessment of indocyanine green-labeled cetuximab to detect xenografted head and neck cancer cell lines. Otolaryngol Head Neck Surg, 2007. 137(5): 729–34.
Withrow, K.P., J.R. Newman, J.B. Skipper, J.P. Gleysteen, J.S. Magnuson, K. Zinn, and E.L. Rosenthal, Assessment of bevacizumab conjugated to Cy5.5 for detection of head and neck cancer xenografts. Technol Cancer Res Treat, 2008. 7(1): 61–6.
Yang, M., E. Baranov, P. Jiang, F.X. Sun, X.M. Li, L. Li, S. Hasegawa, M. Bouvet, M. Al-Tuwaijri, T. Chishima, H. Shimada, A.R. Moossa, S. Penman, and R.M. Hoffman, Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc Natl Acad Sci USA, 2000a. 97(3): 1206–11.
Yang, M., E. Baranov, A.R. Moossa, S. Penman, and R.M. Hoffman, Visualizing gene expression by whole-body fluorescence imaging. Proc Natl Acad Sci USA, 2000. 97(22): 12278–82.
Yang, M., S. Hasegawa, P. Jiang, X. Wang, Y. Tan, T. Chishima, H. Shimada, A.R. Moossa, and R.M. Hoffman, Widespread skeletal metastatic potential of human lung cancer revealed by green fluorescent protein expression. Cancer Res, 1998. 58(19): 4217–21.
Yang, M., P. Jiang, Z. An, E. Baranov, L. Li, S. Hasegawa, M. Al-Tuwaijri, T. Chishima, H. Shimada, A.R. Moossa, and R.M. Hoffman, Genetically fluorescent melanoma bone and organ metastasis models. Clin Cancer Res, 1999. 5(11): 3549–59.
Yankeelov, T.E., M. Lepage, A. Chakravarthy, E.E. Broome, K.J. Niermann, M.C. Kelley, I. Meszoely, I.A. Mayer, C.R. Herman, K. McManus, R.R. Price, and J.C. Gore, Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging, 2007. 25(1): 1–13.
Yee, D.J., V. Balsanek, and D. Sames, New tools for molecular imaging of redox metabolism: development of a fluorogenic probe for 3 alpha-hydroxysteroid dehydrogenases. J Am Chem Soc, 2004. 126(8): 2282–3.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Zinn, K.R. (2010). Overview of Cancer Detection and Monitoring Strategies. In: Rosenthal, E., Zinn, K. (eds) Optical Imaging of Cancer. Springer, New York, NY. https://doi.org/10.1007/978-0-387-93874-5_5
Download citation
DOI: https://doi.org/10.1007/978-0-387-93874-5_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-93873-8
Online ISBN: 978-0-387-93874-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)